Registration of resolutions adopted at Pharmexa's Ordinary General Meeting and Extraordinary General Meeting

Pharmexa has been informed about two objections sent to the Danish Commerce and
Companies Agency regarding the legality of the resolutions adopted at the
Ordinary General Meeting on April 28, 2009 and the Extraordinary General
Meeting on May 5, 2009. Pharmexa disagrees with the objections and find them
unfounded. As a result of the objections the registration of the resolutions
may be delayed. 


Hørsholm, May 13, 2009


Achim Kaufhold
Chief Executive Officer


Additional information:
Claude Mikkelsen, Senior Vice President, Finance & Investor Relations, tel +45
4516 2525 or +45 4060 2558